June 22, 2023
Sens. Mike Lee (R-UT), Ted Budd (R-NC), and Marsha Blackburn (R-TN) introduced a bill aimed at empowering patients and improving the outdated regulation of islet transplantation, a cutting-edge treatment for individuals with Type 1 Diabetes. Rep. Matt Rosendale (R-MT) introduced a companion bill in the House of Representatives. Focused on patient-centered care, this effort would move islets to a more appropriate regulatory framework.
Of the bill, Sen Lee said, “This bill holds tremendous potential for those living with this chronic condition, offering the possibility of reducing or eliminating the need for injected insulin. By redefining islets as organs rather than drugs, we aim to align the regulatory framework with the scientific advancements in the field. This will promote innovation, enhance patient access to islet transplantation, and potentially improve outcomes and quality of life for individuals with Type 1 Diabetes. It is time for Congress to act and address the regulatory mismatch that currently hinders progress in islet transplantation. By granting regulatory authority to the appropriate agencies and prohibiting the classification of islets as drugs, we can unlock the full potential of this life-changing procedure.”
You can see the full article, bill, and endorsements at his website.
Mike Lee should run for president. He’s right on the money. Thank you for visiting! Please visit us again on the 4th of July for more updates.